Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2.900 JPY | -0,28% | -1,91% | -0,22% |
30/04 | Winst toerekenbaar aan eigenaars Otsuka Holdings stijgt 26% in Q1 | MT |
09/04 | H. Lundbeck, Otsuka Pharmaceutical willen goedkeuring van Amerikaanse FDA voor combinatietherapie tegen PTSS | MT |
Vakgebied
Aantal werknemers: 9 421
Verkoop per activiteit
JPY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
System Integration
64,5
%
| 541 671 | 62,9 % | 630 185 | 64,5 % | +16,34% |
Service and Support
35,5
%
| 319 350 | 37,1 % | 347 185 | 35,5 % | +8,72% |
Verkoop per regio
JPY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Japan
100,0
%
| 861 022 | 100,0 % | 977 370 | 100,0 % | +13,51% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Yuji Otsuka
PSD | President | 70 | 01-11-81 |
Koichi Hisano
CMP | Compliance Officer | - | - |
Minoru Sakurai
CTO | Chief Tech/Sci/R&D Officer | 67 | 01-03-79 |
Hironobu Saito
ADM | Chief Administrative Officer | 74 | 01-08-68 |
Hironobu Tsurumi
BRD | Director/Board Member | 68 | 01-03-79 |
Katsuhiro Yano
BRD | Director/Board Member | 68 | 01-03-79 |
Director/Board Member | 73 | 01-03-73 | |
Director/Board Member | 71 | 01-03-76 | |
Tatsumi Murata
AUD | Comptroller/Controller/Auditor | - | - |
Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yuji Otsuka
PSD | President | 70 | 01-11-81 |
Director/Board Member | 71 | 01-03-76 | |
Director/Board Member | 73 | 01-03-73 | |
Katsuhiro Yano
BRD | Director/Board Member | 68 | 01-03-79 |
Hironobu Saito
ADM | Chief Administrative Officer | 74 | 01-08-68 |
Tetsuo Saito
BRD | Director/Board Member | 70 | 01-03-16 |
Hironobu Tsurumi
BRD | Director/Board Member | 68 | 01-03-79 |
Jiro Makino
BRD | Director/Board Member | 71 | 01-03-04 |
Minoru Sakurai
CTO | Chief Tech/Sci/R&D Officer | 67 | 01-03-79 |
Makiko Hamabe
BRD | Director/Board Member | 59 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 380 004 240 | 220 756 312 ( 58,09 %) | 802 484 ( 0,2112 %) | 58,09 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
PERSOL HOLDINGS CO.,LTD. 1.29% | 30 000 000 | 1.29% | 41 788 200 $ |
OTSUKA CORPORATION 0.21% | 802 200 | 0.21% | 16 047 570 $ |
AVILEN INC. 18.84% | 1 140 000 | 18.84% | 14 850 826 $ |
SIOS CORPORATION 17.95% | 1 593 300 | 17.95% | 6 267 293 $ |
GIG WORKS INC. 4.90% | 1 080 000 | 4.90% | 4 014 868 $ |
RICOH COMPANY, LTD. 0.07% | 439 885 | 0.07% | 3 819 799 $ |
100 000 | 0.02% | 2 821 466 $ | |
382 204 | 0.03% | 2 068 587 $ | |
13 100 | 0.02% | 1 408 105 $ | |
NIHON KNOWLEDGE CO,LTD. 9.74% | 134 000 | 9.74% | 1 237 264 $ |
Bedrijfsgegevens
Bedrijven van de groep
Naam | Categorie en sector |
---|---|
ReCor Medical, Inc.
ReCor Medical, Inc. Pharmaceuticals: MajorHealth Technology ReCor Medical, Inc. develops novel therapeutic ultrasound catheter technologies The firm develops a therapeutic non-focused ultrasound system for performing renal denervation in patients with resistant hypertension. The company was founded by Mano Iyer and Jacques Seguin in July 2009 and is headquartered in Palo Alto, CA. |
Pharmaceuticals: Major
|
Sector
Verkoop per activiteit
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-0,22% | 7,09 mld. | |
+5,34% | 35,9 mld. | |
+4,27% | 15,76 mld. | |
-6,76% | 9,06 mld. | |
-46,16% | 4,48 mld. | |
+6,99% | 2,9 mld. | |
-15,24% | 2,32 mld. | |
-0,88% | 2,29 mld. | |
-18,29% | 1,99 mld. | |
-31,01% | 1,17 mld. |
- Beurs
- Aandelen
- Koers 4768
- Onderneming Otsuka Corporation